Form 4: Disc Medicine Executive Acquires Shares and Stock Options

William Jacob Savage, Chief Medical Officer of Disc Medicine, Inc., reports acquisition of shares and stock options.

Summary

• On January 10, 2024, William Jacob Savage, the Chief Medical Officer of Disc Medicine, Inc. (IRON), acquired 18,535 shares of common stock at $0.00.
• Following this transaction, Savage directly owns 21,535 shares of common stock.
• Savage also acquired stock options for 27,800 shares of common stock with an exercise price of $63.90 on January 10, 2024.
• These options vest over time, with 25% vesting on January 10, 2025, and the remainder vesting in 36 equal monthly installments, contingent upon continued service.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares and options by a key executive suggests confidence, but it's a routine filing.

Positives

• The acquisition of shares and stock options by the Chief Medical Officer could be interpreted as a positive sign, indicating confidence in the company's future prospects.

Future Outlook

The vesting schedule of the stock options indicates a long-term commitment from the Chief Medical Officer, with vesting continuing over the next three years contingent on continued service.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. They provide insights into the actions of company executives and their confidence in the company's stock.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, reflecting confidence from a key executive.

Key Dates